{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:14:50Z","timestamp":1782231290015,"version":"3.54.5"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Sleep Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.5664\/jcsm.11566","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T14:00:12Z","timestamp":1738850412000},"page":"1245-1260","source":"Crossref","is-referenced-by-count":2,"title":["Current knowledge on the pathophysiology of idiopathic hypersomnia and potential mechanisms of action for low-sodium oxybate treatment"],"prefix":"10.1007","volume":"21","author":[{"given":"Logan D.","family":"Schneider","sequence":"first","affiliation":[{"name":"Stanford University Sleep Medicine Center, Stanford University School of Medicine, Redwood City, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Cairns","sequence":"additional","affiliation":[{"name":"BioSerenity, Columbia, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Ruoff","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Bogan","sequence":"additional","affiliation":[{"name":"University of South Carolina School of Medicine, Columbia, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.2147\/NSS.S396641"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2020.10.014"},{"key":"e_1_3_2_4_2","volume-title":"International Classification of Sleep Disorders.","author":"American Academy of Sleep Medicine","year":"2023","unstructured":"American Academy of Sleep Medicine . International Classification of Sleep Disorders. 3rd ed, text revision . Darien, IL : American Academy of Sleep Medicine ; 2023 .","edition":"3"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2015.08.007"},{"key":"e_1_3_2_6_2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders.","year":"2022","unstructured":"American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed, text revision . Washington, DC : American Psychiatric Association ; 2022 .","edition":"5"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2014.09.016"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2017.03.009"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.2922"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6882"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2019.05.007"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7722"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2015.10.005"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/32.6.753"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25141"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab072.496"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2022.101709"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2869.2010.00824.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12383"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750230066013"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.2147\/NSS.S386021"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2020.08.034"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00919-1"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.11014"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8344"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2020.11.040"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8482"},{"key":"e_1_3_2_28_2","unstructured":"Saad R Black J Bogan RK et\u00a0al . Diagnosed prevalence of idiopathic hypersomnia among adults in the United States . Poster presented at: Annual Meeting of the Academy of Managed Care Pharmacy Nexus; October 16-19; Orlando FL."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2016.09.015"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27658"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23818"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab021"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.5050"},{"key":"e_1_3_2_34_2","unstructured":"Xywav\u00ae (Calcium Magnesium Potassium and Sodium Oxybates) Oral Solution CIII [prescribing information] Palo Alto CA : Jazz Pharmaceuticals Inc .; 2023 ."},{"key":"e_1_3_2_35_2","unstructured":"Jazz Pharmaceuticals . Jazz Pharmaceuticals announces U.S. FDA approval of Xywav\u00ae (calcium magnesium potassium and sodium oxybates) oral solution for idiopathic hypersomnia in adults . http:\/\/investor.jazzpharma.com\/news-releases\/news-release-details\/jazz-pharmaceuticals-announces-us-fda-approval-xywavr-calcium . Accessed February 14 2023 ."},{"key":"e_1_3_2_36_2","unstructured":"US Food and Drug Administration . Clinical review for Binosto NDA 202344 . https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2012\/202344Orig1s000MedR.pdf . Accessed February 28 2023 ."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511093331917"},{"key":"e_1_3_2_38_2","unstructured":"US Food and Drug Administration . Quantitative labeling of sodium potassium and phosphorus for human over-the-counter and prescription drug products . https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/quantitative-labeling-sodium-potassium-and-phosphorus-human-over-counter-and-prescription-drug . Accessed October 11 2022 ."},{"key":"e_1_3_2_39_2","unstructured":"Xyrem\u00ae (Sodium Oxybate) Oral Solution CIII [prescribing information] Palo Alto CA : Jazz Pharmaceuticals Inc .; 2023 ."},{"key":"e_1_3_2_40_2","unstructured":"Lumryz\u2122 (Sodium Oxybate) for Extended-Release Oral Solution CIII [prescribing information] Chesterfield MO : Avadel CNS Pharmaceuticals ; 2023 ."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2003.12.013"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.10.001"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-017922-3.50103-9"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/8755122514545518"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620120-00004"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsae067.0630"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00368-9"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.10698"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.2147\/NSS.S369122"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.9328"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2017.10.005"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/27.7.1327"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27994"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13087"},{"key":"e_1_3_2_55_2","unstructured":"Provigil [package insert] North Wales PA : Teva Pharmaceuticals ; 2018 ."},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2023.101766"},{"key":"e_1_3_2_57_2","unstructured":"Ritalin [package insert] East Hanover NJ : Novartis Pharmaceuticals Corporation ; 2019 ."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.9326"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2022.0015"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"A278","DOI":"10.1093\/sleep\/zsae067.0650","article-title":"Safety and efficacy of KP1077 in a phase 2, double-blind, randomized trial in patients with idiopathic hypersomnia [abstract 0650]","volume":"47","author":"Braeckman R","year":"2024","unstructured":"Braeckman R, Drake C, Gallo D, Vaughn B, AbdelFattah I . Safety and efficacy of KP1077 in a phase 2, double-blind, randomized trial in patients with idiopathic hypersomnia [abstract 0650] . Sleep. 2024 ; 47 ( Suppl 1 ): A278 .","journal-title":"Sleep."},{"key":"e_1_3_2_61_2","unstructured":"Zevra Therapeutics . Zevra Therapeutics announces top-line data from the phase 2 clinical trial of KP1077 for idiopathic hypersomnia . https:\/\/investors.zevra.com\/news-releases\/news-release-details\/zevra-therapeutics-announces-top-line-data-phase-2-clinical . Accessed July 1 2024 ."},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2020.1714435"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2014.01.021"},{"key":"e_1_3_2_64_2","unstructured":"PR Newswire . Harmony Biosciences announces topline data from phase 3 INTUNE study evaluating pitolisant in patients with idiopathic hypersomnia . https:\/\/www.prnewswire.com\/news-releases\/harmony-biosciences-announces-topline-data-from-phase-3-intune-study-evaluating-pitolisant-in-patients-with-idiopathic-hypersomnia-301955736.html . Accessed November 7 2023 ."},{"key":"e_1_3_2_65_2","unstructured":"Wakix [package insert] Plymouth Meeting PA: Harmony Biosciences; 2022 ."},{"key":"e_1_3_2_66_2","unstructured":"US Food and Drug Administration . FDA drug safety communication: FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease . https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-review-finds-additional-data-supports-potential-increased-long . Accessed February 16 2023 ."},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113515062"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24459"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.572912"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1080\/01658107.2022.2041046"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.652674"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004685"},{"key":"e_1_3_2_73_2","doi-asserted-by":"crossref","unstructured":"Morse AM Chen A Steininger TL Macfadden W . Effects of low-sodium oxybate on 24-hour total sleep time: data from a phase 3 clinical study in adults with idiopathic hypersomnia . Poster presented at: Annual Meeting of the American Academy of Neurology ; April 22-27 2023; Boston MA.","DOI":"10.1212\/WNL.0000000000203244"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2009.05.004"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12468"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0382-z"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00904-6"},{"key":"e_1_3_2_78_2","volume-title":"The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications.","author":"Berry RB","year":"2020","unstructured":"Berry RB, Quan SF, Abreu AR, et\u00a0al ; for the American Academy of Sleep Medicine . The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Version 2.6 . Darien, IL : American Academy of Sleep Medicine ; 2020 .","edition":"2"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4160-6645-3.00002-5"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00032.2011"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12371"},{"issue":"3","key":"e_1_3_2_82_2","first-page":"195","article-title":"A two process model of sleep regulation","volume":"1","author":"Borb\u00e9ly AA","year":"1982","unstructured":"Borb\u00e9ly AA . A two process model of sleep regulation . Hum Neurobiol. 1982 ; 1 ( 3 ): 195 \u2013 204 .","journal-title":"Hum Neurobiol."},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-05-03526.1995"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2015.06.007"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2009.03.051"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085255"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.11.032"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.08.012"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-018-0097-x"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2244-05.2006"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(97)01157-0"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.2741\/1043"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2016.08.005"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6196"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301534"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00424"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsz156"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2012.03.001"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbscr.2019.02.001"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/27.7.1255"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2869.2012.01061.x"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2011.02.028"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.4908"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2022.06.016"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2021.01.031"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/32.2.181"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2869.2002.00284.x"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.10.1553"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab285"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.2080"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1053\/smrv.2001.0168"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1038\/hgv.2015.31"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1007\/s41105-021-00349-2"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-022-00298-w"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.14146"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsac160"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112225119"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175877"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsx140"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab050"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24710"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.04.038"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12201"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2021.01.018"},{"key":"e_1_3_2_126_2","unstructured":"Sunosi\u00ae (Solriamfetol) Tablets [prescribing information] New York : Axsome Therapeutics Inc .; 2022 ."},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25423"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113566"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab012"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/120.7.1173"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8994"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.9818"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003432"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009555"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy223"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.027169"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-008-9035-6"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.10.028"},{"issue":"1","key":"e_1_3_2_139_2","first-page":"71","article-title":"Striatal dopamine and gamma-hydroxybutyrate","volume":"2","author":"Roth RH","year":"1976","unstructured":"Roth RH . Striatal dopamine and gamma-hydroxybutyrate . Pharmacol Ther B. 1976 ; 2 ( 1 ): 71 \u2013 88 .","journal-title":"Pharmacol Ther B."},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1971.tb09588.x"},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)28674-8"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.10.011"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(08)63808-X"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90061-1"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00604-4"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-36-11469.2003"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(96)13016-0"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.3592"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsac079.384"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2009.02.008"},{"key":"e_1_3_2_151_2","unstructured":"DrugBank . Baclofen . https:\/\/go.drugbank.com\/drugs\/DB00181 . Accessed September 18 2023."},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0080-14.2014"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1159\/000151683"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.110"},{"key":"e_1_3_2_155_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2018.03.002"},{"key":"e_1_3_2_156_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.112.078154"},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00543-z"},{"key":"e_1_3_2_158_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2005.05.001"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.10.1337"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.3171"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/13.1.24"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2017.07.030"},{"key":"e_1_3_2_163_2","doi-asserted-by":"crossref","unstructured":"Mignot E Bogan RK Black J et\u00a0al . Effects of sodium oxybate treatment on sleep architecture in paediatric patients with narcolepsy . Poster presented at: Biennial World Sleep ; September 20-25 2019; Vancouver Canada.","DOI":"10.1016\/j.sleep.2019.11.715"},{"issue":"2","key":"e_1_3_2_164_2","first-page":"35","article-title":"Long-term follow-up on the effects of sodium oxybate on daytime sleepiness and sleep architecture in patients with narcolepsy type 1","volume":"76","author":"Peraita-Adrados R","year":"2023","unstructured":"Peraita-Adrados R, Bell\u00f3n JM, Lillo-Triguero L, L\u00f3pez-Esteban P, Medrano-Mart\u00ednez P . Long-term follow-up on the effects of sodium oxybate on daytime sleepiness and sleep architecture in patients with narcolepsy type 1 . Rev Neurol. 2023 ; 76 ( 2 ): 35 \u2013 40 .","journal-title":"Rev Neurol."},{"key":"e_1_3_2_165_2","unstructured":"ClinicalTrials.gov . Clarithromycin mechanisms in hypersomnia syndromes NCT04026958 . https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04026958 . Accessed April 14 2023 ."},{"key":"e_1_3_2_166_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.paid.2023.112427"},{"key":"e_1_3_2_167_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10608-015-9686-4"},{"key":"e_1_3_2_168_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab220"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:06:17Z","timestamp":1770109577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.11566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":167,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.5664\/jcsm.11566"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.11566","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}